Giorgi-Renault S[au] - Search Results

Year	Number of Results
1982	1
1983	3
1988	1
1989	3
1991	3
1992	1
1994	5
1995	1
1996	2
1998	1
2000	2
2002	2
2003	1
2005	1
2008	1
2009	1
2010	2
2021	0

1

Drugs that inhibit tubulin polymerization: the particular case of podophyllotoxin and analogues.

Desbène S, Giorgi-Renault S. Desbène S, et al. Among authors: giorgi renault s. Curr Med Chem Anticancer Agents. 2002 Jan;2(1):71-90. doi: 10.2174/1568011023354353. Curr Med Chem Anticancer Agents. 2002. PMID: 12678752 Review.

2

A new synthetic approach to functionalize pyrimido[4,5-b]quinoline-2,4(1H,3H)-diones via a three-component one-pot reaction.

Aknin K, Desbène-Finck S, Helissey P, Giorgi-Renault S. Aknin K, et al. Among authors: giorgi renault s. Mol Divers. 2010 Feb;14(1):123-30. doi: 10.1007/s11030-009-9154-8. Epub 2009 May 19. Mol Divers. 2010. PMID: 19452259

3

Design of a composite ethidium-netropsin-anilinoacridine molecule for DNA recognition.

Carrasco C, Helissey P, Haroun M, Baldeyrou B, Lansiaux A, Colson P, Houssier C, Giorgi-Renault S, Bailly C. Carrasco C, et al. Among authors: giorgi renault s. Chembiochem. 2003 Jan 3;4(1):50-61. doi: 10.1002/cbic.200390014. Chembiochem. 2003. PMID: 12512076

4

A multicomponent reaction for the one-pot synthesis of 4-aza-2,3-didehydropodophyllotoxin and derivatives.

Tratrat C, Giorgi-Renault S, Husson HP. Tratrat C, et al. Among authors: giorgi renault s. Org Lett. 2002 Sep 19;4(19):3187-9. doi: 10.1021/ol0200908. Org Lett. 2002. PMID: 12227745

5

Heterocyclic quinones. XIV. Pharmacomodulation in a series of 11H-indolo[3,2-c]quinolinediones: synthesis and cytotoxicity of 8-substituted 11H-indolo[3,2-c]quinoline-7,10-diones.

Helissey P, Giorgi-Renault S, Renault J, Cros S. Helissey P, et al. Among authors: giorgi renault s. Chem Pharm Bull (Tokyo). 1989 Mar;37(3):675-9. doi: 10.1248/cpb.37.675. Chem Pharm Bull (Tokyo). 1989. PMID: 2752476

6

Structure-mutagenicity relationships in a series of indolo[3,2-c]quinoline-1,4-diones that have shown cytotoxic properties on leukemia cells.

Min S, Helissey P, Callais F, Giorgi-Renault S, Festy B. Min S, et al. Among authors: giorgi renault s. Mutat Res. 1992 Oct;280(4):225-31. doi: 10.1016/0165-1218(92)90052-2. Mutat Res. 1992. PMID: 1382223

7

[4-Aza-2,3-didehydropodophyllotoxins: new lignan with antitumor activity obtained from one-step synthesis].

Giorgi-Renault S. Giorgi-Renault S. Ann Pharm Fr. 2005 Jan;63(1):63-8. doi: 10.1016/s0003-4509(05)82252-7. Ann Pharm Fr. 2005. PMID: 15803102 French.

8

Inhibition of eukaryotic DNA topoisomerase I and II activities by indoloquinolinedione derivatives.

Riou JF, Helissey P, Grondard L, Giorgi-Renault S. Riou JF, et al. Among authors: giorgi renault s. Mol Pharmacol. 1991 Nov;40(5):699-706. Mol Pharmacol. 1991. PMID: 1658605

9

Design, synthesis, and biological evaluation of the first podophyllotoxin analogues as potential vascular-disrupting agents.

Labruère R, Gautier B, Testud M, Seguin J, Lenoir C, Desbène-Finck S, Helissey P, Garbay C, Chabot GG, Vidal M, Giorgi-Renault S. Labruère R, et al. Among authors: giorgi renault s. ChemMedChem. 2010 Dec 3;5(12):2016-25. doi: 10.1002/cmdc.201000305. ChemMedChem. 2010. PMID: 20979080

10

Heterocyclic Quinones. 4. A new highly cytotoxic drug: 6,7-bis(1-aziridinyl)-5,8-quinazolinedione.

Renault J, Giorgi-Renault S, Baron M, Mailliet P, Paoletti C, Cros S, Voisin E. Renault J, et al. Among authors: giorgi renault s. J Med Chem. 1983 Dec;26(12):1715-9. doi: 10.1021/jm00366a011. J Med Chem. 1983. PMID: 6644740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results